Findings

What do systematic reviews say?

21 questions · 23 findings · 2 reviews

No studies found 10 · 43.5%GRADE not reported 0 · 0%Very low 5 · 21.7%Low 7 · 30.4%Moderate 1 · 4.3%High 0 · 0%

Major bleeding · people > 18 years of age with a diagnosed deep vein thrombosis

Idrabiotaparinux may leads to lower major bleeding compared with idraparinux (low certainty).

1 finding from 1 review

Pentasaccharides for the treatment of deep vein thrombosis 2017 · Cochrane Headline outcomes only
RR 0.21 [0.06, 0.71]
1 study · 755 participants
Low